With National Prostate Health Month quickly approaching in September, the Prostate Cancer Program at the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) has several expert sources that may be helpful for stories you are working on now or in the future.  We are always glad to make a connection with these or any of our other health experts.

Read on for more about:

  • Prostate Cancer Active Surveillance Study – the nation's largest clinical trial of active surveillance
  • A BIDMC-developed tool to assess and strengthen quality of life
  • Treatment options, including a non-invasive alternative to surgery and clinical trials.

About 1 in 9 men will be diagnosed with prostate cancer during their lifetime, according to the American Cancer Society. BIDMC is committed to supporting patients as they navigate their diagnosis and treatment options through a holistic approach.

  • Active Surveillance – The Prostate Cancer Active Surveillance Study, (PASS), the nation's largest clinical trial of active surveillance, is designed to identify and validate biomarkers — proteins, DNA, RNA and hormones — that predict aggressive prostate cancer. BIDMC is the only academic medical center in the Northeast participating in this study, under the leadership of Principal Investigators and urologic surgeons Dr. Andrew Wagner and Dr. Peter Chang.
  • The Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP) is a convenient tool for health care providers to measure urinary, bowel, sexual and vitality/hormonal health. This quality of life instrument, developed by clinician researchers at Beth Israel Deaconess Medical Center, including Dr. Peter Chang, was designed specifically for use in the routine clinical care of prostate cancer patients.
  • CyberKnife – CyberKnife is a non-invasive alternative to surgery that can treat both cancerous and non-cancerous tumors anywhere in the body, including the prostate. BIDMC experts have utilized the tool for many years, including radiation oncologist Dr. Irving Kaplan.
  • The latest treatment options, including clinical trials – Medical oncologists Dr. Glenn Bubley, Dr. David Einstein and Dr. Rupal Bhatt can speak to current prostate cancer therapies in the clinic as well as those currently being studied in clinical trials.